# Codex Execution Review: phase5-slice61cg-package95-sponsor-susar-expedited-reporting-boundary

## Verdict

**Accept after parent remediation.** Package 95 satisfies the bounded model-free source-closure contract. This verdict does not approve a clinical semantic result, enrollment rule, subject decision or publication.

## Worker Outputs

- `worker_01` created the initial configuration and parent checklist for 12 owned and 5 read-only attached sources.
- `worker_02` created the deterministic regression module and the dry-run prepare artifacts.
- `worker_03` performed the independent read-only attack review. It exposed positive-rule checks that could be satisfied by unrelated `base_rule`, keyword or forbidden-text fields, then re-tested the repaired p1132 object and disagreement counterexamples in the same session.
- All workers used the declared Cursor `default` route without fallback. Worker output was treated as implementation or review input, never as acceptance evidence.

## Manager Assessment

The governed Hermes finite-code packet declares no separate manager. Codex performed parent integration, corrected the worker artifacts, reran the deterministic checks and owns this acceptance decision.

## Codex Independent Verification

- Reopened the execution contract, frozen plan, configuration, checklist, tests, prepare artifacts, generated prompt and all three worker reports.
- Preserved the exact p1126 recipient set: all participating investigators, trial institutions, ethics committees, drug regulatory authorities and health authorities.
- Preserved the p1127 agency name `国家药品监督管理总局药品审评中心`, distinct from the later `国家药品审评机构` wording.
- Preserved p1127/p1132 object logic as `(肯定相关 OR 可疑) AND 非预期 AND 严重`; causality disagreement applies only inside that object scope and cannot replace it.
- Preserved p1128's 7-day initial report plus following 8-day follow-up, p1129's `非（致死或危及生命）的SUSAR` 15-day rule, p1130's two alternative starts and single end, and p1131's split between all post-study SAE sent to the sponsor and SUSAR-only expedited reporting.
- Preserved p1133-p1137 as one cross-package list introduced by `以下情况一般不作为快速报告内容`; p1134/p1135 inherit that non-absolute lead-in, and p1137 retains applicant, individual safety report form and national drug review agency.
- Corrected the original semantic oracle so positive assertions read the authoritative `exception_rule` instead of concatenating positive and forbidden fields. Added exception-only contradiction tests for p1126, p1128, p1131, p1132 and p1133, including independent p1132 object and disagreement-polarity mutations.
- Confirmed all 12 owned and 5 attached refs remain zero-candidate, p1124 is structural, p1125-p1135 remain `post_treatment_execution`, and `required_candidate_source_refs=[]`.
- Rebuilt evidence remains `12 owned / 5 attached / 17 total`, `claims_complete=false`, prompt `35200` characters. SHA-256: config `33f145fd55a73e0dda83fb36ee4eb3f2ffc5792106fcda16aec271f79d2a1fcb`; test `c1e174c963b061f376fc98b730b3ed3a3153c6a12f85b4d8439351a29d1390a7`; prompt `ba5383a1d22ae33ad00983efcf77ecd6c5359173390a7ffc46cc92f78edfcfb6`.
- Effective verification used worktree `.venv` Python 3.12.13: focused `65 passed, 5 warnings`; Package 88-95 adjacent `394 passed, 5 warnings`; whole Phase closure previously passed `929`, protocol and Agent suite `1198` with `58` warnings, governance `30`; JSON, scoped diff check and execution audit passed.
- A resumed check accidentally invoked macOS system Python 3.9 and failed during Pydantic import before test setup because that interpreter cannot evaluate the project's Python 3.10+ union syntax. No product code was changed for that invalid environment; the same suite passed under the declared worktree interpreter.

## Cleanup Decision

After `review-gate`, archive only runner-owned Package 95 prompt, context, plan, log and route-manifest process files through the workflow guard. Preserve worker reports, review, metrics, source config, tests, prepare artifacts and checkpoint. Delete only Package 95 generated Python cache files.
